CRISPR Therapeutics to Participate Upcoming Investor Conferences

On May 2, 2023 CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, reported that members of its senior management team are scheduled to participate in fireside chats at the following investor conferences in May (Press release, CRISPR Therapeutics, MAY 2, 2023, View Source [SID1234630834]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Bank of America Securities 2023 Health Care Conference
Date: Tuesday, May 9, 2023
Time: 10:40 a.m. PT

JMP Securities Life Sciences Conference
Date: Monday, May 15, 2023
Time: 11:30 a.m. ET

A live webcast of the fireside chats will be available on the "Events & Presentations" page in the Investors section of the Company’s website at View Source A replay of the webcasts will be archived on the Company’s website for 14 days following the presentation.